CIK 0001781174
- Emerging growth company
Acrivon Therapeutics, Inc.
Sign in to watch- Ticker
- ACRV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 825125532
- Phone
- +1 617-207-8979
- Business address
- 480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
- 4 Shares withheld for taxes Chief Operating Officer gave up 613 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 60,256 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 558 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 284 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 79,616 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 99 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 184 shares (to pay taxes)
- 4 Shares withheld for taxes EVP - Business Operations gave up 490 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 368 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Development Officer gave up 402 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 613 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 59,765 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 558 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Operating Officer acquired 10,000 shares (option exercise)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 99 shares (to pay taxes)
Page 7 of 11 · 206 filings